Achira, a startup focused on drug discovery, has launched with a $33 million seed funding round. The company combines artificial intelligence and physics-based methods to develop atomic-level simulation models aimed at accelerating drug discovery processes. Co-founders include notable figures in the field, such as @jchodera and @Tkaraletsos. The team, which also includes experts from @Sca_DS and @UniLeipzig, emphasizes the potential of their technology to revolutionize protein design and enhance the efficiency of drug development. The launch has garnered positive recognition within the scientific community, highlighting the importance of integrating AI into molecular simulation for future applications.